Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Carmat SA

Healthcare US CKMTF

NoneUSD
0.00(0%)

Last update at 2024-09-11T10:46:41.618580Z

Day Range

--
LowHigh

52 Week Range

12.7512.75
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap315.94M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-51.05600M
  • Revenue TTM0.91M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 0.30M
  • Diluted EPS TTM-3.84

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -55.74200M -63.73700M -38.67441M -44.28469M -43.71303M
Minority interest - - - - -
Net income -53.68100M -61.87300M -36.96343M -42.64867M -41.72907M
Selling general administrative - - - 20.90M 24.15M
Selling and marketing expenses - - - - -
Gross profit -28.44700M -40.51000M -24.39926M -28.29881M -30.67241M
Reconciled depreciation -1.48400M 8.44M 8.83M 1.55M 1.64M
Ebit -44.23000M -48.14000M -28.97590M -42.52684M -42.77372M
Ebitda -45.71400M -39.70200M -20.55897M -41.66918M -41.84559M
Depreciation and amortization -1.48400M 8.44M 8.42M 0.86M 0.93M
Non operating income net other - - - - -
Operating income -51.92200M -60.40800M -36.41151M -42.39381M -42.77372M
Other operating expenses 44.58M 50.47M 28.90M 42.48M 42.77M
Interest expense 3.82M 3.32M 2.53M 1.78M 0.94M
Tax provision -2.06200M -1.86300M -1.71098M -1.63602M -1.98392M
Interest income - - - - -
Net interest income -3.82000M -3.31600M -2.52556M -1.78215M -0.93751M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -2.06200M -1.86300M -1.71098M -1.63602M -1.98392M
Total revenue 0.37M 2.34M 0.00000M 0.00000M 0.00000M
Total operating expenses 15.76M 7.62M 4.50M 14.18M 12.09M
Cost of revenue 28.82M 42.85M 24.40M 28.30M 30.67M
Total other income expense net -3.82000M -3.32900M -2.26290M -1.89088M -0.93930M
Discontinued operations - - - - -
Net income from continuing ops -53.68000M -61.87400M -36.96343M -42.64867M -41.72911M
Net income applicable to common shares -53.70000M -61.87300M -36.96300M -42.64867M -41.72907M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 85.24M 69.08M 59.84M 64.68M 36.83M
Intangible assets - 0.09M 0.02M 0.03M 0.09M
Earning assets - - - - -
Other current assets 0.00100M 0.00200M 2.68M 0.00050M 0.95M
Total liab 83.27M 82.63M 66.52M 40.21M 29.35M
Total stockholder equity 1.97M -13.54900M -6.68831M 24.47M 7.48M
Deferred long term liab - - - - -
Other current liab 5.70M 5.18M 4.41M 3.25M 3.03M
Common stock 0.91M 0.62M 0.52M 0.50M 0.37M
Capital stock 0.91M 0.62M 0.52M 0.50M 0.37M
Retained earnings -68.90900M -98.83600M -36.96343M -230.12875M -187.48007M
Other liab - 2.31M 0.62M 0.41M 0.30M
Good will - - - - -
Other assets 0.00100M 0.00100M 0.55M 0.47M -0.00000M
Cash 51.43M 39.19M 35.98M 55.51M 25.30M
Cash and equivalents - - - - -
Total current liabilities 14.87M 13.70M 12.50M 8.60M 10.65M
Current deferred revenue - - -10.09436M - -
Net debt 3.93M 12.83M 2.96M -39.09064M -20.65002M
Short term debt 2.64M 0.13M 0.08M - -
Short long term debt 2.64M 0.13M 0.08M - -
Short long term debt total 55.36M 52.02M 38.94M 16.41M 4.65M
Other stockholder equity 69.97M 84.66M 29.75M 254.09M 194.59M
Property plant equipment - 6.78M 6.41M 5.11M 5.56M
Total current assets 77.76M 61.67M 52.86M 59.06M 30.69M
Long term investments - - - - -
Net tangible assets - 0.87M 7.80M 38.95M 20.45M
Short term investments - - - - -
Net receivables 8.90M 8.13M 4.11M 2.94M 4.58M
Long term debt 52.72M 51.89M 38.86M 16.41M 4.65M
Inventory 17.44M 14.34M 9.90M - -
Accounts payable 6.53M 8.39M 8.01M 5.35M 7.62M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.77M 0.54M 0.55M 0.47M 0.49M
Deferred long term asset charges - - - - -
Non current assets total 7.47M 7.41M 6.98M 5.61M 6.14M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.99000M 0.01M -0.07200M 0.01M -0.01333M
Change to liabilities 0.00000M 0.39M 2.66M -2.26965M 1.79M
Total cashflows from investing activities -2.00000M -1.75000M -2.29700M -0.63635M -2.30671M
Net borrowings - 10.12M 20.00M 11.45M 11.45M
Total cash from financing activities 68.60M 65.13M 25.81M 71.09M 5.06M
Change to operating activities - 0.19M -1.23100M 1.90M -0.77351M
Net income -51.92200M -61.87300M -36.96343M -42.64867M -41.72907M
Change in cash 12.24M 3.21M -19.52110M 30.20M 19.23M
Begin period cash flow 39.19M 35.98M 55.51M 25.30M 6.07M
End period cash flow 51.43M 39.19M 35.98M 55.51M 25.30M
Total cash from operating activities -54.37500M -60.16900M -43.03234M -40.24497M -38.17388M
Issuance of capital stock 69.08M 55.01M 5.81M 0.13M 0.01M
Depreciation -1.48400M 8.44M 8.42M 0.86M 0.93M
Other cashflows from investing activities -2.00000M -1.80000M -1.80000M -1.80000M -1.80000M
Dividends paid - - - - -
Change to inventory - -9.56000M -17.41594M -0.11841M -0.19401M
Change to account receivables - -0.46400M -0.46400M -0.46400M -0.46400M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.00100M 10.11M 20.00M 70.95M 5.05M
Change to netincome -0.70000M 10.08M 10.01M 1.46M 0.95M
Capital expenditures 1.75M 1.76M 2.33M 0.65M 2.29M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - -9.69700M -17.01140M -0.21717M 1.69M
Stock based compensation - - - - -
Other non cash items -0.96900M 2.96M 2.53M 1.76M 0.94M
Free cash flow -56.12300M -61.93200M -45.35807M -40.89369M -40.46726M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CKMTF
Carmat SA		 - -% - - - 347.18 1565.21 213.05 -3.8854
ABT
Abbott Laboratories		 0.02 0.02% 86.99 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 1.70 0.58% 295.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 4.20 5.69% 77.95 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.01 0.02% 47.69 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Carmat SA

36, avenue de l'Europe, Vélizy-Villacoublay, France, 78140

Key Executives

Name Title Year Born
Mr. Stephane Piat CEO & Director 1971
Ms. Pascale d'Arbonneau CFO & Head of investor relations NA
Mr. Eric Richez Sales & Bus. Devel. Director 1961
Mr. Francesco Arecchi Marketing Mang. NA
Ms. Raouia Bouyanzer HR Director NA
Dr. Petrus Jansen Chief Medical Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions